Protocols:Hypertension (HTN) and Heart Conditions (Simple)

Cardiologists, Internists, and Internal Medicine

Hypertension (HTN) is a chronic disease characterized by a gradual elevation in the blood pressure of the arteries. Although there is no strict threshold that allows us to define the line separating risk and safety, according to international consensus a sustained systolic pressure above 139 mmHg or a sustained diastolic pressure above 89 mmHg are associated with a measurable increase in the risk of atherosclerosis and are thus considered to be clinically significant hypertension.

Hypertension is associated with considerably elevated rates of morbidity and mortality. For this reason, it is considered to be one of the most important public health problems, especially in developed countries, where it affects nearly one billion people worldwide. Hypertension is an asymptomatic disease and easy to detect, but can lead to serious and even lethal complications if not treated on time.

Chronic hypertension is the most important modifiable risk factor for the development of cardiovascular diseases, as well as for cerebrovascular and renal diseases. We also know that men have a higher predisposition for developing hypertension that women. This situation changes when women reach menopause.

Several risk factors have been associated with the development of cardiovascular diseases. Among these is oxidative stress, which leads to elevated concentrations of lipid peroxidation products.
In these cases that cardiac tissue wears out and deteriorates, cellular regeneration becomes of vital importance. It is necessary to apply the organ’s cellular extracts in order to revitalize the worn out muscle.

Protocol 1 (Moderate HTN)

• Bioenzym

 

Bioenzym tablets, take 2 tablets in the morning (on an empty stomach) and 2 tablets at night (on an empty stomach). Treatment should be taken continuously for at least 3 months, and then re-evaluate.

 

Protocol 2 (Preventive, Moderate HTN)

• Cellorgane Multi-complex No. 3 Heart, Arteries, and Veins. Oral

 

Cellorgane Multi-complex tablets. Take 2 tablets in the morning (on an empty stomach) and 2 tablets at night (on an empty stomach). Treatment should be taken continuously for at least 6 months, and then re-evaluate.

• Bioenzym

 

Bioenzym tablets, take 2 tablets in the morning (on an empty stomach) and 2 tablets at night (on an empty stomach). Treatment should be taken continuously for at least 3 months, and then re-evaluate.

 

Protocol 3 (Moderate HTN with Cardiovascular Compromise)

• Cellorgane Multi-complex No. 3 Heart, Arteries, and Veins.

 

Administer 2 ml daily by deep intramuscular injection for 5 days, rest 2 days, and adminis-ter another complete treatment course of 2 ml daily for 5 days (two boxes). Treatment should be repeated after 6 months.

• Cellorgane Multi-complex No. 3 Heart, Arteries, and Veins. Oral

 

Cellorgane Multi-complex tablets. Take 2 tablets in the morning (on an empty stomach) and 2 tablets in the evening (on an empty stomach). Treatment should be taken continu-ously for at least 6 months, and then re-evaluate.

Protocol 4 (Severe HTN) 

• Cellorgane Multi-complex No. 3 Heart, Arteries, and Veins. Injectable

 

Administer 2 ml daily by deep intramuscular injection for 5 days, rest 2 days, and adminis-ter another complete treatment of 2 ml daily for 5 days (two boxes). Treatment should be repeated after 6 months.

• Cellorgane Multi-complex No. 3 Heart, Arteries, and Veins. Oral

 

Cellorgane Multi-complex tablets. Take 2 tablets in the morning (on an empty stomach) and 2 tablets in the evening (on an empty stomach). Treatment should be taken continu-ously for at least 6 months, and then re-evaluate.

•  Injectable Cellorgane Multi-complex Men/Women (General Support)

 

After finishing Cellorgane Multi-complex No. 3, administer 2 ml daily by deep intramuscular injection for 5 days, rest 2 days, and administer another complete treatment course of 2 ml daily for 5 days (two boxes). Acts as Multi-organ support. Treatment should be repeated after 6 months.

• Bioenzym

 

Bioenzym tablets, take 2 tablets in the morning (on an empty stomach) and 2 tablets at night (on an empty stomach). Treatment should be taken continuously for at least 3 months, and then re-evaluate.

 

Protocol 5 (HTN + Risk of Metabolic Syndrome) 

• Revercell

 

To be administered concurrently with Cellorgane Multi-complex No. 3 Heart, Arteries, and Veins Injectable, one white capsule in the morning, one white/red capsule in the afternoon, and one red capsule at night before meals, continuously for six months, and then re-evaluate.